论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
肠道微生物群在帕金森病进展中的作用及中药干预机制
Authors Huan P, Wang L, He Z, He J
Received 18 March 2022
Accepted for publication 7 July 2022
Published 26 July 2022 Volume 2022:18 Pages 1507—1520
DOI https://doi.org/10.2147/NDT.S367016
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Yuping Ning
Abstract: Parkinson’s disease (PD) is a common degenerative disease of the nervous system that seriously affects the quality of life of the patients. The pathogenesis of PD is not yet fully clear. Previous studies have confirmed that patients with PD exhibit obvious gut microbiota imbalance, while intervention of PD by regulating the gut microbiota has become an important approach to the prevention and treatment of this disease. Traditional Chinese medicine (TCM) has been shown to be safe and effective in treating PD. It has the advantages of affecting multiple targets. Studies have shown TCM can regulate gut microbiota. However, the specific mechanism of action is still unclear. Therefore, this article will mainly discuss the association of the alteration of the gut microbiota and the incidence of PD, the advantages of TCM in treating PD, and the mechanism of regulating gut microbiota by TCM to treat PD. It will clarify the target and mechanism of TCM treating PD by acting gut microbiota and provided a novel methodology for the prevention and treatment of PD.
Keywords: Parkinson’s disease, gut microbiota, traditional Chinese medicine, pathogenesis